Abstract
Stress creates disharmony in the body's natural environment and thus causes an imbalance in the normal physiological system. The term diabetes describes a group of metabolic disorders, characterized and identified by the presence of hyperglycemia. Essential factors identified to initiate hyperglycemia are excess body weight, high cholesterol, high blood pressure, and lifestyle changes like stress, genetics, etc. Different types of stress and related conditions like depression, anxiety, etc., cause pancreatic β-cell dysfunction and insulin resistance, the prime risk factors in the progression of type 2 diabetes. The neuroendocrine system plays a pivotal role in countering psychological stress is the hypothalamus-pituitary-adrenal (HPA) axis, which secretes glucocorticoids (GCs), e.g., cortisol is the principal stress-responsive natural steroid hormone. The stress system essentially hampers the body's homeostasis and develops serious clinical manifestations. Glucocorticoids exert a strong physiological impact on glucose metabolism directly or indirectly, cause hyperglycemic effect and play an important role in the development of type 2 diabetes observed in patients suffering from chronic stress, Cushing’s syndrome, or patients on long term GCs therapy. This review provides a clear outline on the pathways and mechanisms of stress-linked type 2 diabetes.
Keywords: Type 2 diabetes, stress, glucocorticoids, Hypothalamus-Pituitary-Adrenal (HPA) axis, hyperglycemia, insulin resistance.
Current Diabetes Reviews
Title:Stress Etiology of Type 2 Diabetes
Volume: 18 Issue: 9
Author(s): Sunena*Dina Nath Mishra
Affiliation:
- Geeta Institute of Pharmacy, Panipat -132145, Haryana, India
Keywords: Type 2 diabetes, stress, glucocorticoids, Hypothalamus-Pituitary-Adrenal (HPA) axis, hyperglycemia, insulin resistance.
Abstract: Stress creates disharmony in the body's natural environment and thus causes an imbalance in the normal physiological system. The term diabetes describes a group of metabolic disorders, characterized and identified by the presence of hyperglycemia. Essential factors identified to initiate hyperglycemia are excess body weight, high cholesterol, high blood pressure, and lifestyle changes like stress, genetics, etc. Different types of stress and related conditions like depression, anxiety, etc., cause pancreatic β-cell dysfunction and insulin resistance, the prime risk factors in the progression of type 2 diabetes. The neuroendocrine system plays a pivotal role in countering psychological stress is the hypothalamus-pituitary-adrenal (HPA) axis, which secretes glucocorticoids (GCs), e.g., cortisol is the principal stress-responsive natural steroid hormone. The stress system essentially hampers the body's homeostasis and develops serious clinical manifestations. Glucocorticoids exert a strong physiological impact on glucose metabolism directly or indirectly, cause hyperglycemic effect and play an important role in the development of type 2 diabetes observed in patients suffering from chronic stress, Cushing’s syndrome, or patients on long term GCs therapy. This review provides a clear outline on the pathways and mechanisms of stress-linked type 2 diabetes.
Export Options
About this article
Cite this article as:
Sunena *, Mishra Nath Dina, Stress Etiology of Type 2 Diabetes, Current Diabetes Reviews 2022; 18 (9) : e240222201413 . https://dx.doi.org/10.2174/1573399818666220224140934
DOI https://dx.doi.org/10.2174/1573399818666220224140934 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Research on the Aortic Elasticity in Patients with Type 1 Diabetes Mellitus Complicated with Hypertension
Current Medical Imaging Peculiarities of the Anticoagulant Properties for the Newly Synthesized Preparations of Coumarin-Related Compounds
Cardiovascular & Hematological Disorders-Drug Targets Immunobiologic Agents in Dermatology
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Early Vascular Ageing (EVA): Definitions and Clinical Applicability
Current Hypertension Reviews Dronedarone – A New Alternative for Management of Atrial Fibrillation
Recent Patents on Cardiovascular Drug Discovery Subject Index To Volume 2
Current Immunology Reviews (Discontinued) Virtual Screening, Docking, Synthesis and Bioactivity Evaluation of Thiazolidinediones as Potential PPARγ Partial Agonists for Preparation of Antidiabetic Agents
Letters in Drug Design & Discovery The Effect of DPP-4i on Endothelial Function and Arterial Stiffness in Patients with Type 2 Diabetes: A Systematic Review of Randomized Placebo-controlled Trials
Current Pharmaceutical Design High Throughput Metabolomics in Clinical Studies: Review and New Applications to Remote Ischemic Preconditioning
Current Topics in Medicinal Chemistry Phosphorylated and O-GlcNAc Modified IRS-1 (Ser1101) and -2 (Ser1149) Contribute to Human Diabetes Type II
Protein & Peptide Letters rDNA Mediated Bioconjugates: Fusion Proteins and their Intended Use in Medicine
Current Topics in Medicinal Chemistry Nasal <i>In-situ</i> Gel: An Approach to Enhance Therapeutic Benefits of the Drug
Drug Delivery Letters Therapeutic Potential of Amniotic Fluid Derived Mesenchymal Stem Cells Based on their Differentiation Capacity and Immunomodulatory Properties
Current Stem Cell Research & Therapy Identification of Phenolic Compounds from Nettle as New Candidate Inhibitors of Main Enzymes Responsible on Type-II Diabetes
Current Drug Discovery Technologies Role of Neuronal Guidance Cues in the Pathophysiology of Obesity: A Peripheral and Central Overview
Current Pharmaceutical Design lGnRH-III - a Promising Candidate for Anticancer Drug Development
Protein & Peptide Letters <i>Dillenia Indica</i> Fruit Extract Suppressed Diet-induced Obesity in Rats by Down-regulating the mRNA Level of Proadipogenic Transcription Factors and Lipid Metabolizing Enzymes
Current Nutrition & Food Science Levels of Estrogen Receptors α and β in Frontal Cortex of Patients with Alzheimers Disease: Relationship to Mini-Mental State Examination Scores
Current Alzheimer Research Aberrant DNA Methylation and Prostate Cancer
Current Genomics Role of Advanced Glycation End Products (AGEs) and Oxidative Stress in Diabetic Retinopathy
Current Pharmaceutical Design